Utrecht-based Scinus secures €3 million to tackle one of the biggest challenges in cell therapy | EU-Startups

Scinus Group, a Utrecht-based startup that develops and distributes bioreactor technology for stem cell cultivation, has closed a €3 million strategic investment round to accelerate the global rollout of the Osilaris™ cell expansion platform. The round was led by Myosotis Investments. Existing shareholders, including the company’s founders and the Demcon Innovation Fund, also participated in […] The post Utrecht-based Scinus secures €3 million to tackle one of the biggest challenges in cell therapy appeared first on EU-Startups.